LIVE: WHO’s Tedros briefs media on Ebola vaccine

Key Concepts

• Public Health Emergency of International Concern (PHEIC): The highest level of alert issued by the WHO for an extraordinary event that poses a public health risk to other states.
• Bundibugyo Virus: A rare species of the Ebola virus for which there are currently no approved vaccines or therapeutics.
• R&D Blueprint: A WHO strategy to accelerate the development of medical countermeasures (vaccines, diagnostics, and treatments) during epidemics.
• Index Case: The first documented patient in an epidemiological investigation.
• Chain of Transmission: The sequence of events by which a pathogen is passed from one individual to another.
• No-Regret Policy: An emergency response framework where resources are deployed rapidly and aggressively to prevent further spread, even if the full scale of the outbreak is not yet known.

---

1. Overview of the Outbreak

The WHO Director-General has declared a PHEIC regarding the Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda. While the situation is classified as a high risk at national and regional levels, it does not currently meet the criteria for a "pandemic emergency."

• Confirmed Cases: 51 confirmed cases in the DRC (Ituri and North Kivu provinces) and two in Uganda.
• Suspected Cases: Nearly 600 suspected cases and 139 suspected deaths.
• Timeline: The outbreak is believed to have started around April 20th, with a "super-spreading event" occurring on May 5th. Detection was delayed due to the rarity of the Bundibugyo strain, the endemic nature of other diseases (malaria, typhoid) with similar symptoms, and severe security challenges.

2. Challenges and Complexity

The response is complicated by several critical factors:

• Security and Displacement: The Ituri province is a conflict zone with over 100,000 newly displaced people, hindering surveillance and healthcare access.
• Diagnostic Limitations: Existing test kits are optimized for the Zaire strain of Ebola and do not reliably detect the Bundibugyo strain.
• Logistics: Transporting samples from remote areas like Ituri to the national laboratory in Kinshasa (1,700 km away) is hampered by limited flight availability and infrastructure.
• Healthcare-Associated Transmission: Deaths among health workers have been reported, signaling a need for improved infection prevention and control (IPC).

3. Response Strategy and Methodology

The WHO is employing a "no-regret" policy, prioritizing immediate action over waiting for perfect data.

• Surveillance and Contact Tracing: The primary defense remains identifying chains of transmission, isolating suspected cases, and tracing contacts.
• Community Engagement: Experts emphasized that the response must be community-led to avoid resistance. Treatment centers are being placed as close to affected communities as possible.
• Research and Development:
  • Vaccines: There are no approved vaccines for the Bundibugyo strain. A candidate vaccine (rVSV-Bundibugyo) is in the pipeline but is 6–9 months away. A ChAdOx1-platform vaccine is being explored, with potential clinical trial doses in 2–3 months, pending animal data.
  • Therapeutics: The WHO is working to establish safe patient referral pathways while preparing for trials of promising candidate therapeutics.

4. Key Arguments and Perspectives

• Travel Restrictions: The WHO does not support travel bans, citing that they are not evidence-based and can hinder the movement of essential supplies and personnel. They advocate for point-of-exit screening instead.
• WHO’s Role: Dr. Tedros clarified that the WHO does not replace national health authorities but provides technical, operational, and coordination support. He noted that the primary responsibility for detection lies with the affected countries.
• Funding: While $3.9 million has been allocated from the contingency fund, officials emphasized that funding alone cannot solve the logistical and security-related complexities of the region.

5. Notable Quotes

• Dr. Tedros (Director-General): "We don't replace the country's work; we only support them... it is very difficult to follow a simplistic approach and say blame this or that."
• Professor Lucille Bloomberg (Chair, Emergency Committee): "Ebola is not airborne. It requires direct contact with blood and body fluids... travel restrictions are not supported under the IHR recommendations."

6. Synthesis and Conclusion

The Ebola Bundibugyo outbreak in the DRC and Uganda is a serious, complex emergency exacerbated by regional conflict and the lack of specific medical countermeasures. The WHO’s strategy focuses on scaling up diagnostic capacity, strengthening community-based surveillance, and maintaining a "no-regret" response to cut transmission chains. Success depends on the ability to navigate extreme logistical hurdles and maintain the trust of local communities, rather than relying solely on international intervention or simplistic solutions.